Welcome to the new

Allow us to reintroduce ourselves...

We are pleased to announce that the newly designed Fisher BioServices website is officially up and running! While the design has changed, the URL remains the same and can be accessed by typing into your browser.

Read more to learn about the content, design, and how to provide your feedback.  We hope you like our new look!

Content: Blog

Pooling Biospecimen Collections into “Synthetic” Cohorts to Promote Personalized Medicine

Large longitudinal studies have become impractical on many levels. At well over $100 per patient enrolled, the traditional large cohort study has become cost-prohibitive. Nor is cost the only factor: another is time. By their very nature, cohort studies can take decades to yield benefits, both at the individual as well as the population level.1 However, these studies are still needed both for public health research and to support the implementation of personalized medicine.

Topic: Biobanking and Biorepository, Topic: Public..........

Personalized Medicine and Validation of Next-Generation Sequencing

Personalized medicine and next-generation sequencing (NGS) are two trends producing major swings in the healthcare industry. As previously discussed on Doe & Ingalls blog, here are some points you should be familiar with if your strategy touches upon either of these.

Topic: Qualification / Validation, Topic: Laborato..........

The Evolution of Public Health Research: Sir Austin Bradford Hill and the Cigarette-Rolling Machine

In 1923, a general practitioner in rural Virginia received a phone call from a friend, a surgeon at a hospital in Richmond. A middle-aged man with an uncommon form of cancer had been admitted to the hospital - would he like to come and see the patient, the friend asked. It was a rare opportunity to examine and diagnose an unusual illness first-hand. The country doctor was happy to visit the hospital and further his education, especially since he'd doubted seeing more than one or two similar patients over the rest of his career.

Topic: Biobanking and Biorepository, Topic: Labora..........

ISBER 2016 Annual Meeting: Sample Integrity You Can Bank On

We are pleased to announce our participation at the International Society for Biological and Environmental Repositories (ISBER) 2016 Annual Meeting in Berlin, Germany. This year's theme, Breaking Down Walls: Unifying Biobanking Communities to Secure our Sustainability, will focus on different fields of biobanking and how biobanking communities can act in concert to increase sustainability and to secure the future of biobanking. ISBER 2016 is the premier global event in the field of repository and specimen management and we are honored to showcase our services and products in conjunction with our parent company, Thermo Fisher Scientific at Booth #63.

Topic: Biobanking and Biorepository, Content: Blog

Exploring Immunotherapies to Treat Crohn's Disease

Crohn’s disease and ulcerative colitis affect more than 1.6 million Americans, according to the Crohn’s and Colitis Foundation of America. Unfortunately, patients with Crohn’s disease are left with limited treatment options and no cure for the condition. This could change with new research supporting the use of immunotherapies to treat Crohn’s disease.

Topic: Cell Therapy Solutions, Content: Blog

Managing the Cold Chain to Minimize Pre-Analytical Variability: ISBER 2015 Flashback

The value of your work lies in the integrity of your specimens. Ensuring samples are maintained at the proper temperature throughout all processes is imperative to maximal long term viability and usability. This means not only during the processing and preparation of samples for analysis or storage—it also means during the transportation process. Moving samples between physical locations is a necessary part of biobanking, whether the locations are separated by a lab, a building or even a continent.

With ISBER 2016 right around the corner, let's take a trip down memory lane and review last year's workshop, presented by Alex Esmon PhD, global cold storage product manager at Thermo Fisher Scientific, on the importance of maintaining the cold chain during sample transport.

Topic: Biobanking and Biorepository, Content: Blog

Large-Scale Freezing of Biologics: Advantages and Challenges

Biopharmaceutical companies often produce millions of units of bulk biological materials that are then distributed for clinical use. This represents a significant supply chain challenge, as these materials need to be maintained within very specific environmental parameters. Temperature, humidity, and stress during material handling must be tightly controlled to prevent degradation of quality. Large-scale freezing of biologics provides a safe and effective method of storing biological materials, but this approach comes with unique challenges.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

Amazing Samples: Skin

Despite being the largest in the human body it’s easy to forget about skin as an organ, unless your research or practice directly involves it. It’s what we use to interact with the world and present ourselves. No one else, other than doctors, will really start thinking about your spleen or pituitary gland when they look at you. But just as with any other cell type, there is great research being conducted around skin.

Topic: Cell Therapy Solutions, Topic: Amazing Samp..........

The Growing Public Health Concern Surrounding Zika

Over the past several weeks, the Zika virus has morphed from an obscure disease into an international public health emergency, gaining global attention. This has left the public health research community with many questions; Where did the disease originate? How is it transmitted? How do we work together to develop and distribute a vaccine?

In this blog we'll explore the existing information surrounding the Zika virus and some of the challenges associated with vaccine development.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

EU Commission Guidelines on Good Distribution Practice of IMP

Over the past few years there has been a notable increase in the number of temperature-controlled clinical supplies being transported all over the world. This increase can be attributed to the fact that a larger number of clinical trial drugs being tested today are of a biological nature. However, as discussed on the Fisher Clinical Services INSIGHTS blog, until recently little thought was given to ambient drug (generally set to be stored within 15°C – 25°C) being transported through a temperature controlled method as well.

Topic: Cold-Chain Logistics, Topic: GMP Biologics ..........

The Shift to Immunosurveillance in Breast Cancer Treatment

As we've discussed previously on the blog, bio-pharmaceutical entities are scrambling to bring new immunotherapies to the clinic, particularly in the treatment of cancers. The US Food and Drug Administration (FDA) and other regulatory agencies worldwide have already approved several immunotherapies for the treatment of various tumors, including melanoma and non-small cell lung carcinoma (NSCLC). However, pre-clinical and clinical trials to assess the safety and efficacy of investigational immunotherapies for breast cancer have only recently begun.

Topic: Biobanking and Biorepository, Topic: Cell T..........